Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, Pierer Mobility (03/09/2024)

08.09.2024

Valneva: Valneva and Pfizer announced positive immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease vaccine candidate, VLA15, given one year after receiving the first booster dose. The immune response and safety profile of VLA15 one month after receiving the second booster dose were similar to those reported after receiving the first booster dose, showing compatibility with the anticipated benefit of a booster vaccination prior to each Lyme season. There are currently no approved human vaccines for Lyme disease, and VLA15 is the Lyme disease vaccine candidate which has advanced the furthest along the clinical development timeline, with two Phase 3 trials in progress. The Centers for Disease Control and Prevention (CDC) has estimated that approximately 476,000 people in the U.S. are diagnosed and treated for Lyme disease each year and 129,000 cases are reported annually in Europe.
Valneva: weekly performance: -6.38%

Pierer Mobility: Gottfried Neumeister took over the role of Co-CEO at PIERER Mobility AG and KTM AG on September 1, 2024. "I am delighted to welcome Gottfried Neumeister, an experienced and highly successful top manager. He will provide fresh impetus and increasingly take responsibility for tasks from my portfolio," comments Stefan Pierer, CEO of PIERER Mobility. Gottfried Neumeister says:  "I am delighted to be taking a piece of Austria out into the world with over 6,000 great people. The team at PIERER Mobility AG has proven over the years that it is one of the best in the world through innovation and performance. When I think of PIERER Mobility/KTM, attributes such as emotion, passion and performance come to mind, coupled with the will not to stand still, but to constantly strive for improvement and perfection. This makes me all the more happy to be part of this community."
Pierer Mobility: weekly performance: -1.45%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (03/09/2024)


Partners









latest 21st Austria

21st Austria weekly - Valneva, Pierer Mobility (03/09/2024)


08.09.2024, 2022 Zeichen



Valneva: Valneva and Pfizer announced positive immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease vaccine candidate, VLA15, given one year after receiving the first booster dose. The immune response and safety profile of VLA15 one month after receiving the second booster dose were similar to those reported after receiving the first booster dose, showing compatibility with the anticipated benefit of a booster vaccination prior to each Lyme season. There are currently no approved human vaccines for Lyme disease, and VLA15 is the Lyme disease vaccine candidate which has advanced the furthest along the clinical development timeline, with two Phase 3 trials in progress. The Centers for Disease Control and Prevention (CDC) has estimated that approximately 476,000 people in the U.S. are diagnosed and treated for Lyme disease each year and 129,000 cases are reported annually in Europe.
Valneva: weekly performance: -6.38%

Pierer Mobility: Gottfried Neumeister took over the role of Co-CEO at PIERER Mobility AG and KTM AG on September 1, 2024. "I am delighted to welcome Gottfried Neumeister, an experienced and highly successful top manager. He will provide fresh impetus and increasingly take responsibility for tasks from my portfolio," comments Stefan Pierer, CEO of PIERER Mobility. Gottfried Neumeister says:  "I am delighted to be taking a piece of Austria out into the world with over 6,000 great people. The team at PIERER Mobility AG has proven over the years that it is one of the best in the world through innovation and performance. When I think of PIERER Mobility/KTM, attributes such as emotion, passion and performance come to mind, coupled with the will not to stand still, but to constantly strive for improvement and perfection. This makes me all the more happy to be part of this community."
Pierer Mobility: weekly performance: -1.45%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (03/09/2024)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Netfonds AG. CFO Reichelt auf der HIT: "Wir wachsen organisch aus unserem Neugeschäft heraus, nicht über den Markt"




 

Bildnachweis

Aktien auf dem Radar:Polytec Group, CA Immo, Immofinanz, Warimpex, Addiko Bank, Amag, Rosgix, Wiener Privatbank, ams-Osram, Andritz, AT&S, Cleen Energy, FACC, Marinomed Biotech, RBI, Telekom Austria, Oberbank AG Stamm, Flughafen Wien, Agrana, Erste Group, EVN, Kapsch TrafficCom, OMV, Palfinger, Österreichische Post, S Immo, Uniqa, VIG, Wienerberger, DO&CO, Siemens Energy.


Random Partner

Agrana
Die Agrana Beteiligungs-AG ist ein Nahrungsmittel-Konzern mit Sitz in Wien. Agrana erzeugt Zucker, Stärke, sogenannte Fruchtzubereitungen und Fruchtsaftkonzentrate sowie Bioethanol. Das Unternehmen veredelt landwirtschaftliche Rohstoffe zu vielseitigen industriellen Produkten und beliefert sowohl lokale Produzenten als auch internationale Konzerne, speziell die Nahrungsmittelindustrie.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten